If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings
With standout ADC and t-cell engager response data across hard-to-treat cancers
The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments
New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain
The approval was granted by Agenzia Italiana del Farmaco
Transition to a fermentation-based globally integrated CDMO platform
Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy
AI and analytics leader brings extensive expertise in machine learning, GenAI, and life sciences decision intelligence to Lilly’s data science operations
Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.
Diagnostic-guided healthcare platform strengthens leadership team to accelerate AI-driven diagnostics and consumer healthcare expansion
Subscribe To Our Newsletter & Stay Updated
